SPY302.97-0.56 -0.18%
DIA254.35-1.42 -0.56%
IXIC9,368.99-43.37 -0.46%

BTIG Initiates Coverage On BridgeBio Pharma with Buy Rating, Announces Price Target of $49

BTIG initiates coverage on BridgeBio Pharma (NASDAQ:BBIO) with a Buy rating and announces Price Target of $49.

Benzinga · 05/19/2020 11:54

BTIG initiates coverage on BridgeBio Pharma (NASDAQ:BBIO) with a Buy rating and announces Price Target of $49.